These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8043681)

  • 21. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
    Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
    Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-sectional assessment of weekly urea and creatinine clearances in patients on continuous ambulatory peritoneal dialysis.
    Nolph KD; Moore HL; Twardowski ZJ; Khanna R; Prowant B; Meyer M; Ponferrada L
    ASAIO J; 1992; 38(3):M139-42. PubMed ID: 1457833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dietary protein and energy requirements in ESRD patients.
    Kopple JD
    Am J Kidney Dis; 1998 Dec; 32(6 Suppl 4):S97-104. PubMed ID: 9892375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nutritional management of dialysis patients: balancing among nutrient intake, dialysis dose, and nutritional status.
    Nakao T; Matsumoto H; Okada T; Kanazawa Y; Yoshino M; Nagaoka Y; Takeguchi F
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S133-6. PubMed ID: 12612970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dialysis quantity and dietary protein during continuous ambulatory peritoneal dialysis].
    Schmidli M; Jacobs M; Binswanger U
    Klin Wochenschr; 1990 Dec; 69(24):1156-60. PubMed ID: 2135301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of dialysis therapy on insulin resistance in end-stage renal disease: comparison of haemodialysis and continuous ambulatory peritoneal dialysis.
    Kobayashi S; Maejima S; Ikeda T; Nagase M
    Nephrol Dial Transplant; 2000 Jan; 15(1):65-70. PubMed ID: 10607769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant human growth hormone therapy in malnourished dialysis patients: a randomized controlled study.
    Iglesias P; Díez JJ; Fernández-Reyes MJ; Aguilera A; Burgués S; Martínez-Ara J; Miguel JL; Gómez-Pan A; Selgas R
    Am J Kidney Dis; 1998 Sep; 32(3):454-63. PubMed ID: 9740162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The removal index for evaluation of dialysis.
    Chen TW; Huang TP; Liu MC; Wang ML
    Perit Dial Int; 1996; 16(2):128-34. PubMed ID: 9147545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative evaluation of CAPD and PD-plus effectiveness.
    Iles-Smith H; Curwell J; Gokal R
    EDTNA ERCA J; 1999; 25(3):27-9. PubMed ID: 10786491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Weight limitations for weekly urea clearances using various exchange volumes in continuous ambulatory peritoneal dialysis.
    Nolph KD; Jensen RA; Khanna R; Twardowski ZJ
    Perit Dial Int; 1994; 14(3):261-4. PubMed ID: 7948239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Weekly clearances of urea and creatinine on CAPD and NIPD.
    Nolph KD; Twardowski ZJ; Keshaviah PR
    Perit Dial Int; 1992; 12(3):298-303. PubMed ID: 1511047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival comparison between hemodialysis and peritoneal dialysis based on matched doses of delivered therapy.
    Keshaviah P; Collins AJ; Ma JZ; Churchill DN; Thorpe KE
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S48-52. PubMed ID: 11792762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant human insulin-like growth factor-1 induces an anabolic response in malnourished CAPD patients.
    Fouque D; Peng SC; Shamir E; Kopple JD
    Kidney Int; 2000 Feb; 57(2):646-54. PubMed ID: 10652043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adequacy of peritoneal dialysis: does kt/v have the same predictive value as in HD? A multicenter study.
    De Alvaro F; Bajo MA; Alvarez-Ude F; Vigil A; Molina A; Coronel F; Selgas R
    Adv Perit Dial; 1992; 8():93-7. PubMed ID: 1361862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nutritional aspects of chronic renal dialysis.
    Ginn HE
    South Med J; 1969 Dec; 62(12):1471-6. PubMed ID: 5372061
    [No Abstract]   [Full Text] [Related]  

  • 36. Improved urea clearance raises the BUN in continuous peritoneal dialysis.
    Baltzan MA; Shoker AA; Baltzan RB; Pylypchuk GB
    Clin Nephrol; 1996 Mar; 45(3):183-7. PubMed ID: 8706360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein catabolic rate calculations in CAPD patients.
    Keshaviah PR; Nolph KD
    ASAIO Trans; 1991; 37(3):M400-2. PubMed ID: 1751208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis.
    Mottet JJ; Horber FF; Casez JP; Descoeudres C; Jaeger P
    J Bone Miner Res; 1996 Jan; 11(1):96-104. PubMed ID: 8770702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma levels of human atrial natriuretic factor in patients treated by hemodialysis and continuous ambulatory peritoneal dialysis.
    Ando R; Matsuda O; Miyake S; Yoshiyama N
    Nephron; 1988; 50(3):225-8. PubMed ID: 2976122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. QT dispersion in hemodialysis and CAPD patients.
    Kantarci G; Ozener C; Tokay S; Bihorac A; Akoğlu E
    Nephron; 2002 Aug; 91(4):739-41. PubMed ID: 12138280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.